Pennsylvania HB 2521: An Act providing for reimbursement of patient expenses associated with participation in cancer clinical trials and for duties of the Department of Health; and imposing a penalty.

Status: PN 3772 Referred to HEALTH (as of 2018-06-20)

State: Pennsylvania · Session: 2017-2018 · Bill: HB 2521

Sponsors: M. Quinn, Bernstine, Caltagirone, Corr, Deluca, Driscoll, J. Mcneill, Millard, R. Brown, Readshaw, Thomas, Youngblood

View Pennsylvania HB 2521 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.